This forum follows two successful and well-attended forums in 2020 - one that focused on the differential impact of the COVID-19 pandemic on populations internationally, and the second on the impact of disease on racial and ethnic groups and among underserved populations across the United States. The pandemic has revealed new and exacerbated existing health disparities in the United States and worldwide. This forum will explore how pharmaceutical companies and advocates for health disparities communities are addressing disparities through their approach to vaccine development and testing, and what pharmaceutical companies can do to continue to address COVID-related disparities as the vaccine roll-out continues and the virus and patterns of infection and disease change.
Panelists include Moderators Dr. Johnson Lightfoote '73 and Dr. Deborah Winn '73, and panelists Dr. Kenneth Chien '73, Co-Founder at Moderna and Director at the Karolinska Institute; Dr. Uché Blackstock '99, HMS '05, Founder of Advancing Health Equity; and Nina Schwalbe '88, Principal at Spark Street Advisors Advisors.
Registration available soon.